BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23886604)

  • 21. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
    Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
    Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics.
    Longenecker JC; Alfaddagh A; Zubaid M; Rashed W; Ridha M; Alenezi F; Alhamdan R; Akbar M; Bulbanat BY; Al-Suwaidi J
    Int J Cardiol; 2013 Aug; 167(4):1406-11. PubMed ID: 22578736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.
    Zuckerman IH; Yin X; Rattinger GB; Gottlieb SS; Simoni-Wastila L; Pierce SA; Huang TY; Shenolikar R; Stuart B
    J Am Geriatr Soc; 2012 Oct; 60(10):1854-61. PubMed ID: 23003000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.
    Quint JK; Herrett E; Bhaskaran K; Timmis A; Hemingway H; Wedzicha JA; Smeeth L
    BMJ; 2013 Nov; 347():f6650. PubMed ID: 24270505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
    Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
    Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.
    Gong IY; Yan AT; Ko DT; Earle CC; Cheung WY; Peacock S; Hall M; Gale CP; Chan KKW
    Cancer; 2018 Mar; 124(6):1269-1278. PubMed ID: 29211307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of statins and beta-blockers after acute myocardial infarction according to income and education.
    Rasmussen JN; Gislason GH; Rasmussen S; Abildstrom SZ; Schramm TK; Køber L; Diderichsen F; Osler M; Torp-Pedersen C; Madsen M
    J Epidemiol Community Health; 2007 Dec; 61(12):1091-7. PubMed ID: 18000133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M; Carrero JJ; Szummer K; Åkerblom A; Edfors R; Spaak J; Jacobson SH; Andell P; Lindhagen L; Jernberg T
    J Am Coll Cardiol; 2016 Apr; 67(14):1687-97. PubMed ID: 27056774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of recommended medications after myocardial infarction in Austria.
    Winkelmayer WC; Bucsics AE; Schautzer A; Wieninger P; Pogantsch M;
    Eur J Epidemiol; 2008; 23(2):153-62. PubMed ID: 18064529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Beta Blockers and Renin-Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lee PH; Park GM; Kim YH; Yun SC; Chang M; Roh JH; Yoon SH; Ahn JM; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Medicine (Baltimore); 2016 Mar; 95(10):e2971. PubMed ID: 26962802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
    Teng TH; Hung J; Finn J
    Med J Aust; 2010 Mar; 192(6):306-10. PubMed ID: 20230346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of kidney function with cardiovascular medication use after myocardial infarction.
    Winkelmayer WC; Levin R; Setoguchi S
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1415-22. PubMed ID: 18614775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Income-related inequity in initiation of evidence-based therapies among patients with acute myocardial infarction.
    Hanley GE; Morgan S; Reid RJ
    J Gen Intern Med; 2011 Nov; 26(11):1329-35. PubMed ID: 21751053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of β-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction.
    Steinman MA; Zullo AR; Lee Y; Daiello LA; Boscardin WJ; Dore DD; Gan S; Fung K; Lee SJ; Komaiko KD; Mor V
    JAMA Intern Med; 2017 Feb; 177(2):254-262. PubMed ID: 27942713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.